Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
11 hedge funds and large institutions have $1M invested in Plus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
451% more capital invested
Capital invested by funds: $182K → $1M (+$820K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
22% more funds holding
Funds holding: 9 → 11 (+2)
0.38% more ownership
Funds ownership: 0.09% → 0.48% (+0.38%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.12M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$34.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$14.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.28K |
| 5 |
ATPW
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
+$1.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$31K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$63 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $836K | +$1.12M | +22,747 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $68.6K | +$34.1K | +695 | +59% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $47.8K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $26.9K | +$14.9K | +303 | +71% |
|
5
BlackRock
New York
| $10.2K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $6.15K | +$687 | +14 | +9% |
|
|
7
UBS Group
Zurich,
Switzerland
| $4.7K | +$6.28K | +128 | New |
|
|
ATPW
8
Ashton Thomas Private Wealth
Scottsdale,
Arizona
| $1.2K | +$1.62K | +33 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $195 | – | – | – |
|
10
JP Morgan Chase
New York
| $147 | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $69 | +$98 | +2 | New |
|
12
Group One Trading
Chicago,
Illinois
| $1 | – | – | – |
|
|
13
Renaissance Technologies
New York
| – | -$31K | -696 | Closed |
|
|
14
Wells Fargo
San Francisco,
California
| – | -$63 | -1 | Closed |
|
PSTV Hedge Fund Activity: Q2 2024 in Review
11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2024, worth a combined $1M — up 451% from $182K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PSTV positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $1.12M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $31K sold.
- 11 institutional investors held Plus Therapeutics (PSTV) as of Q2 2024, up from 9 in Q1 2024.
- Funds reported $1M of Plus Therapeutics stock for Q2 2024, up 451% quarter-over-quarter.
- 4 funds opened new Plus Therapeutics positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest Plus Therapeutics buyer in Q2 2024 was AIGH Capital Management, an estimated $1.12M added.
- The largest Plus Therapeutics seller in Q2 2024 was Renaissance Technologies, an estimated $31K sold.
Based on aggregated 13F filings for Q2 2024.